Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Cortes

Showing results (211-220 of 791) with videos related to

Pageof 80
Sort By:
Blood|July 3, 2010
Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effectsDan Jones, Su S Chen, Elias Jabbour, et al.
Leukemia & Lymphoma|January 25, 2013
Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosisAziz Nazha, Zeev Estrov, Jorge Cortes, et al.
Blood|July 5, 2003
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AMLElihu H Estey, Peter F Thall, Xuemei Wang, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|September 14, 2010
Systems approaches and algorithms for discovery of combinatorial therapiesJacob D Feala, Jorge Cortes, Phillip M Duxbury, et al.
Annals of Hematology|March 31, 2021
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cellsZhihong Zeng, Charlie Ly, Naval Daver, et al.
Cancer|July 17, 2008
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemiaAhmed Aribi, Hagop Kantarjian, Charles Koller, et al.
Leukemia Research|June 10, 2017
Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcomePreetesh Jain, Sa Wang, Keyur P Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failureAlfonso Quintás-Cardama, Hagop Kantarjian, Susan O'brien, et al.
Plos One|January 12, 2012
Statistical properties and robustness of biological controller-target networksJacob D Feala, Jorge Cortes, Phillip M Duxbury, et al.
International Journal of Cancer|January 3, 2013
Is acute myeloid leukemia a liquid tumor?Maro Ohanian, Stefan Faderl, Farhad Ravandi, et al.
Pageof 80

Showing results (211-220 of 791) with videos related to

Sort By:
Pageof 80
Blood|July 3, 2010
Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effectsDan Jones, Su S Chen, Elias Jabbour, et al.
Leukemia & Lymphoma|January 25, 2013
Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosisAziz Nazha, Zeev Estrov, Jorge Cortes, et al.
Blood|July 5, 2003
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AMLElihu H Estey, Peter F Thall, Xuemei Wang, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|September 14, 2010
Systems approaches and algorithms for discovery of combinatorial therapiesJacob D Feala, Jorge Cortes, Phillip M Duxbury, et al.
Annals of Hematology|March 31, 2021
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cellsZhihong Zeng, Charlie Ly, Naval Daver, et al.
Cancer|July 17, 2008
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemiaAhmed Aribi, Hagop Kantarjian, Charles Koller, et al.
Leukemia Research|June 10, 2017
Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcomePreetesh Jain, Sa Wang, Keyur P Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failureAlfonso Quintás-Cardama, Hagop Kantarjian, Susan O'brien, et al.
Plos One|January 12, 2012
Statistical properties and robustness of biological controller-target networksJacob D Feala, Jorge Cortes, Phillip M Duxbury, et al.
International Journal of Cancer|January 3, 2013
Is acute myeloid leukemia a liquid tumor?Maro Ohanian, Stefan Faderl, Farhad Ravandi, et al.
Pageof 80